Cognetivity Neurosciences Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Cognetivity Neurosciences Ltd is a Canadian healthcare technology company focused on developing diagnostic tools for early detection of cognitive decline. The company’s platform uses artificial intelligence and digital testing methods to assess brain health in clinical and non-clinical environments. Its technology is targeted for applications in neurology, psychiatry, and general health screening. Cognetivity Neurosciences Ltd is headquartered in Vancouver, Canada, and its shares are listed on the CSE.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
CGN
Country
🇨🇦 Canada